Table 5.

The percentage of distribution of fatty acids from plasma phospholipid fraction in patients with hypertension (HTN), coronary heart disease (CHD), type 2 diabetes mellitus, and diabetic nephropathy

Fatty acid	Control	HTN	CHD	Type 2 DM	Diabetic nephropathy
16:0	25.9 ± 3.0	29.3 ± 2.7a	27.8 ± 3.5	26.6 ± 5.2	26.8 ± 2.7
18:0	20.9 ± 3.6	23.2 ± 4.9a	18:0 ± 10.7	14.6 ± 4.1	11.6 ± 3.6a
18:1 n-9	13.0 ± 2.3	12.1 ± 1.5	11.5 ± 3.1	12.0 ± 2.6	14.5 ± 3.1
18:2 n-6	18.6 ± 3.1	14.5 ± 3.1a	17.8 ± 5.0	13.9 ± 5.3	15.1 ± 3.1
18:3 n-6	0.14 ± 0.1	0.4 ± 0.3a	0.1 ± 0.1a	0.2 ± 0.3	0.1 ± 0.2
20:3 n-6	3.4 ± 1.0	3.1 ± 0.9	2.7 ± 1.1	1.7 ± 1.0a	2.0 ± 0.8a
20:4 n-6	9.4 ± 1.8	7.8 ± 2.0a	7.0 ± 2.1a	4.6 ± 1.8a	6.6 ± 2.6a
22:5 n-6	0.7 ± 0.4	0.4 ± 0.4a	1.0 ± 0.9	2.1 ± 0.6a	1.3 ± 0.5a
18:3 n-6/18:2 n-6	0.008	0.026	0.005	0.017	0.008
20:4 n-6/18:2 n-6	0.51	0.54	0.39	0.33	0.43
20:4 n-6/20:3 -6	2.8	2.53	2,59	2.8	3.3
18:3 n-3	0.2 ± 0.1	0.4 ± 0.2a	0.3 ± 0.5	0.1 ± 0.2a	0.1 ± 0.1a
20:5 n-3	0.4 ± 0.4	0.6 ± 0.6	0.1 ± 0.2a	0.3 ± 0.3	0.2 ± 0.3
22:5 n-3	0.5 ± 0.2	0.4 ± 0.5	0.3 ± 0.3a	1.6 ± 1.3	1.7 ± 1.1
22:6 n-3	1.4 ± 0.5	1.2 ± 0.6	0.8 ± 0.4a	0.5 ± 0.4a	0.5 ± 0.3a
20:5 n-3/18:3 n-3	1.8	1.39	0.41	3.2	4.0

All values are expressed as mean ± SD. ^ap <0.05 compared to control.

This data is taken from ref. (16).